Contraction-regulated mTORC1 and protein synthesis: Influence of AMPK and glycogen
- PMID: 32372406
- DOI: 10.1113/JP279780
Contraction-regulated mTORC1 and protein synthesis: Influence of AMPK and glycogen
Abstract
Key points: AMP-activated protein kinase (AMPK)-dependent Raptor Ser792 phosphorylation does not influence mechanistic target of rapamycin complex 1 (mTORC1)-S6K1 activation by intense muscle contraction. α2 -AMPK activity-deficient mice have lower contraction-stimulated protein synthesis. Increasing glycogen activates mTORC1-S6K1. Normalizing muscle glycogen content rescues reduced protein synthesis in AMPK-deficient mice.
Abstract: The mechansitic target of rapamycin complex 1 (mTORC1)-S6K1 signalling pathway regulates muscle growth-related protein synthesis and is antagonized by AMP-activated protein kinase (AMPK) in multiple cell types. Resistance exercise stimulates skeletal muscle mTORC1-S6K1 and AMPK signalling and post-contraction protein synthesis. Glycogen inhibits AMPK and has been proposed as a pro-anabolic stimulus. The present study aimed to investigate how muscle mTORC1-S6K1 signalling and protein synthesis respond to resistance exercise-mimicking contraction in the absence of AMPK and with glycogen manipulation. Resistance exercise-mimicking unilateral in situ contraction of musculus quadriceps femoris in anaesthetized wild-type and dominant negative α2 AMPK kinase dead transgenic (KD-AMPK) mice, measuring muscle mTORC1 and AMPK signalling immediately (0 h) and 4 h post-contraction, and protein-synthesis at 4 h. Muscle glycogen manipulation by 5 day oral gavage of the glycogen phosphorylase inhibitor CP316819 and sucrose (80 g L-1 ) in the drinking water prior to in situ contraction. The mTORC1-S6K1 and AMPK signalling axes were coactivated immediately post-contraction, despite potent AMPK-dependent Ser792 phosphorylation on the mTORC1 subunit raptor. KD-AMPK muscles displayed normal mTORC1-S6K1 activation at 0 h and 4 h post-exercise, although there was impaired contraction-stimulated protein synthesis 4 h post-contraction. Pharmacological/dietary elevation of muscle glycogen content augmented contraction-stimulated mTORC1-S6K1-S6 signalling and rescued the reduced protein synthesis-response in KD-AMPK to wild-type levels. mTORC-S6K1 signalling is not influenced by α2 -AMPK during or after intense muscle contraction. Elevated glycogen augments mTORC1-S6K1 signalling. α2 -AMPK-deficient KD-AMPK mice display impaired contraction-induced muscle protein synthesis, which can be rescued by normalizing muscle glycogen content.
Keywords: AMPK; glycogen; mTORC1; protein synthesis; resistance exercise; skeletal muscle.
© 2020 The Authors. The Journal of Physiology © 2020 The Physiological Society.
Comment in
-
Activity-dependent increases of protein synthesis in skeletal muscle: Sensing the energy levels?J Physiol. 2020 Jul;598(13):2537-2538. doi: 10.1113/JP280081. Epub 2020 May 29. J Physiol. 2020. PMID: 32415782 No abstract available.
-
Clash of the cascades: Release the inhibition.J Physiol. 2020 Oct;598(19):4153-4154. doi: 10.1113/JP280253. Epub 2020 Jul 23. J Physiol. 2020. PMID: 32628271 No abstract available.
Similar articles
-
Muscle-specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism.J Physiol. 2025 Jul;603(14):3961-3971. doi: 10.1113/JP288854. Epub 2025 Jun 30. J Physiol. 2025. PMID: 40587294 Free PMC article.
-
Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.J Physiol. 2009 Apr 1;587(Pt 7):1535-46. doi: 10.1113/jphysiol.2008.163816. Epub 2009 Feb 2. J Physiol. 2009. PMID: 19188252 Free PMC article. Clinical Trial.
-
mTOR Ser1261 is an AMPK-dependent phosphosite in mouse and human skeletal muscle not required for mTORC2 activity.FASEB J. 2025 Jan 31;39(2):e70277. doi: 10.1096/fj.202402064R. FASEB J. 2025. PMID: 39835637
-
Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism.Proc Nutr Soc. 2011 Feb;70(1):92-9. doi: 10.1017/S0029665110003915. Epub 2010 Nov 11. Proc Nutr Soc. 2011. PMID: 21067629 Review.
-
The lysosome: a crucial hub for AMPK and mTORC1 signalling.Biochem J. 2017 Apr 13;474(9):1453-1466. doi: 10.1042/BCJ20160780. Biochem J. 2017. PMID: 28408430 Review.
Cited by
-
Microtubule-mediated GLUT4 trafficking is disrupted in insulin-resistant skeletal muscle.Elife. 2023 Apr 19;12:e83338. doi: 10.7554/eLife.83338. Elife. 2023. PMID: 37073948 Free PMC article.
-
Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting.Autophagy. 2025 Apr;21(4):693-718. doi: 10.1080/15548627.2025.2452149. Epub 2025 Jan 26. Autophagy. 2025. PMID: 39817564 Free PMC article. Review.
-
Neural stimulation suppresses mTORC1-mediated protein synthesis in skeletal muscle.Sci Adv. 2025 Apr 4;11(14):eadt4955. doi: 10.1126/sciadv.adt4955. Epub 2025 Apr 2. Sci Adv. 2025. PMID: 40173236 Free PMC article.
-
Muscle-specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism.J Physiol. 2025 Jul;603(14):3961-3971. doi: 10.1113/JP288854. Epub 2025 Jun 30. J Physiol. 2025. PMID: 40587294 Free PMC article.
-
Carbohydrate-Induced Insulin Signaling Activates Focal Adhesion Kinase: A Nutrient and Mechanotransduction Crossroads.Nutrients. 2020 Oct 15;12(10):3145. doi: 10.3390/nu12103145. Nutrients. 2020. PMID: 33076263 Free PMC article.
References
-
- Apro W, Moberg M, Hamilton DL, Ekblom B, van HG, Holmberg HC & Blomstrand E (2015). Resistance exercise-induced S6K1 kinase activity is not inhibited in human skeletal muscle despite prior activation of AMPK by high-intensity interval cycling. Am J Physiol Endocrinol Metab 308, E470-E481.
-
- Apro W, Wang L, Ponten M, Blomstrand E & Sahlin K (2013). Resistance exercise induced mTORC1 signaling is not impaired by subsequent endurance exercise in human skeletal muscle. Am J Physiol Endocrinol Metab 305,E22-E32.
-
- Ben-Sahra I & Manning BD (2017). mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol 45, 72-82.
-
- Bentzinger CF, Lin S, Romanino K, Castets P, Guridi M, Summermatter S, Handschin C, Tintignac LA, Hall MN & Ruegg MA (2013). Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy. Skelet Muscle 3, 6.
-
- Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ & Yancopoulos GD (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3,1014-1019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources